Benzoyl peroxide
Brand names: Acnecide, PanOxyl, Epiduo (with adapalene), Duac (with clindamycin)
Benzoyl peroxide is a topical keratolytic and antibacterial agent widely used for mild-to-moderate acne vulgaris.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It releases reactive oxygen species that are bactericidal against Cutibacterium acnes, with additional keratolytic and comedolytic effects and no associated bacterial resistance.
Prescribing in practice
- It bleaches hair and dyed fabrics, so warn patients to avoid contact with clothing, towels, bedding and hair.
- Skin irritation, dryness and peeling are common, so start at a lower strength or reduced frequency if poorly tolerated.
- Avoid contact with the eyes, lips and mucous membranes.
Monitoring
No laboratory monitoring is required; assess skin tolerability and acne response clinically.
Counselling the patient
- It can bleach coloured clothing, towels, bedding and hair.
- Some dryness, redness and peeling is expected, especially when starting.
- Use sun protection, as skin may be more sensitive to sunlight.
Evidence & guidelines
NICE recommends benzoyl peroxide-containing regimens as first-line options for acne vulgaris.
Reference: SmPC Acnecide / Duac / Epiduo; NICE NG198 (Acne 2021); BAD Acne Guideline; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acne Severity Classification (IGA Scale) · Acne
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Rh(D) Immune Globulin Dosage for Maternal-Fetal Haemorrhage · Haematology in Pregnancy
- AREDS Classification of Age-related Macular Degeneration · Macular Degeneration
- Diabetic Macular Oedema (DMO) Classification · Diabetic Retinopathy
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD